Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Mast cells are immune sentinels that participate in the defense against bacteria and parasites. Resident within the joint, mast cells become activated in human rheumatoid arthritis and are implicated in the pathogenesis of experimental murine synovitis. However, their arthritogenic role remains undefined. Using a model of autoantibody-induced arthritis, we show that mast cells contribute to the initiation of inflammation within the joint by elaboration of IL-1. Mast cells become activated to produce this cytokine via the IgG immune complex receptor FcγRIII. Interestingly, mast cells become dispensable for the perpetuation of arthritis after delivery of IL-1, highlighting the contribution of this lineage to arthritis induction. These findings illuminate a mechanism by which mast cells can participate in the pathogenesis of autoimmune inflammatory arthritis and provide insights of potential relevance to human rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611
Self-citationHow antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease
Matsumoto, I., Maccioni, M., Lee, D. M., Maurice, M., Simmons, B., Brenner, M., Mathis, D., & Benoist, C. (2002) · Nature Immunology · doi:10.1038/ni772 · Cited by 329
Self-citationChronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1573 · Cited by 287
Cited by
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
Galli, S. J., Grimbaldeston, M., & Tsai, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2327 · Cited by 738
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Mast Cell Function: A New Vision of an Old Cell
da Silva, E. Z. M., Jamur, M. C., & Oliver, C. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414545334 · Cited by 604
Metcalfe, D. D. (2008) · Blood · doi:10.1182/blood-2007-11-078097 · Cited by 536
Notch signalling drives synovial fibroblast identity and arthritis pathology
Wei, K., Korsunsky, I., Marshall, J. L., Gao, A., Watts, G. F. M., Major, T., Croft, A. P., Watts, J., Blazar, P. E., Lange, J. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2222-z · Cited by 528
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
Self-citationMechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Chou, R. C., Kim, N. D., Sadik, C. D., Seung, E., Lan, Y., Byrne, M. H., Haribabu, B., Iwakura, Y., & Luster, A. D. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.018 · Cited by 342
“This is consistent with the finding that in the mast celldeficient Kit/Kit strain, a single dose of exogenous IL-1b was able to ‘‘jump start’’ arthritis and additional exogenous IL-1b was not needed to maintain arthritis in this mast cell-deficient strain (Nigrovic et al., 2007).”
ResultSelf-citationGomez, C. R., Nomellini, V., Faunce, D. E., & Kovacs, E. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.016 · Cited by 328
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
Palmer, G., Talabot‐Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E., & Gabay, C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24305 · Cited by 313
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells
Moulin, D., Donzé, O., Talabot-Ayer, D., Mézin, F., Palmer, G., & Gabay, C. (2007) · Cytokine · doi:10.1016/j.cyto.2007.09.013 · Cited by 309
Caspase 1–independent activation of interleukin‐1β in neutrophil‐predominant inflammation
Guma, M., Ronacher, L., Liu‐Bryan, R., Takai, S., Karin, M., & Corr, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24959 · Cited by 304
Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 296
Mast cells – key effector cells in immune responses
Metz, M., & Maurer, M. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.003 · Cited by 290
Hill, J. A., Bell, D. A., Brintnell, W., Yue, D., Wehrli, B., Jevnikar, A. M., Lee, D. M., Hueber, W., Robinson, W. H., & Cairns, E. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072051 · Cited by 275
Self-citationInterleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis
Noordenbos, T., Yeremenko, N., Gofita, I., van de Sande, M., Tak, P. P., Caňete, J. D., & Baeten, D. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33396 · Cited by 270
Regulation of Mast Cell Responses in Health and Disease
Gilfillan, A. M., & Beaven, M. A. (2011) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v31.i6.30 · Cited by 259
Mast Cells: Multifaceted Immune Cells with Diverse Roles in Health and Disease
Rao, K. N., & Brown, M. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.023 · Cited by 242
The significant role of mast cells in cancer
Khazaie, K., Blatner, N. R., Khan, M. W., Gounari, F., Gounaris, E., Dennis, K., Bonertz, A., Tsai, F.-N., Strouch, M. J., Cheon, E., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9286-z · Cited by 222
“It is also known that MC can induce production of IL-1β by macrophages, at least in the pathogenesis of rheumatoid arthritis [64].”
BackgroundReview: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
Nigrovic, P. A. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38615 · Cited by 217
Self-citationAlpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases
Bencherif, M., Lippiello, P. M., Lucas, R., & Marrero, M. B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0525-1 · Cited by 202
“Mast cells also contribute to initiation of autoantibody-mediated arthritis via IL-1 [25].”
BackgroundDendritic cells, T cells and their interaction in rheumatoid arthritis
Wehr, P., Purvis, H., Law, S.-C., & Thomas, R. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13256 · Cited by 189
Nigrovic, P. A., Gray, D. H. D., Jones, T., Hallgren, J., Kuo, F. C., Chaletzky, B., Gurish, M., Mathis, D., Benoist, C., & Lee, D. M. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080407 · Cited by 184
Self-citationNakamura, Y., Kambe, N., Saito, M., Nishikomori, R., Kim, Y.-G., Murakami, M., Núñez, G., & Matsue, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082179 · Cited by 183
“Because MCs reside in multiples tissues and also participate in experimental models of arthritis (32) and encephalomyelitis (33–35), it is possible that these cells play a role in disease pathogenesis not only in inflammasome, for IL-1 secretion (Fig.”
BackgroundMast Cells Contribute to Autoimmune Inflammatory Arthritis via Their Tryptase/Heparin Complexes
Shin, K., Nigrovic, P. A., Crish, J., Boilard, E., McNeil, H. P., Larabee, K. S., Adachi, R., Gurish, M. F., Gobezie, R., Stevens, R. L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.647 · Cited by 161
“Further studies in this animal model revealed that MCs are activated by IgG Fc receptors and can contribute to joint inflammation by elaborating IL-1 (19).”
BackgroundInfluentialSelf-citationApproaches for Analyzing the Roles of Mast Cells and Their Proteases In Vivo
Galli, S. J., Tsai, M., Marichal, T., Tchougounova, E., Reber, L. L., & Pejler, G. (2015) · Advances in Immunology · doi:10.1016/bs.ai.2014.11.002 · Cited by 101
Metadata
- Authors
- Nigrovic, P. A., Binstadt, B. A., Monach, P. A., Johnsen, A., Gurish, M., Iwakura, Y., Benoist, C., Mathis, D., & Lee, D. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-02-13
- Volume
- 104
- Issue
- 7
- Pages
- 2325-2330
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2110578003
- Cited by
- 179
- References
- 5
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.